Nu Skin downgraded to Neutral from Overweight at JPMorgan JPMorgan downgraded Nu Skin to Neutral saying the underlying business is weaker than it expected with little visibility following the company's Q2 results. The firm cut its price target for shares in half to $50 from $100. Nu Skin closed yesterday down $11.40 to $46.52 after reporting Q2 results.
News For NUS From The Last 14 Days
Check below for free stories on NUS the last two weeks.